target,target_id,target_uniprot,target_species,ligand,ligand_id,ligand_species,ligand_pubchem_cid,smiles,inchi,inchikey,type,action,action_comment,endogenous,primary_target,concentration_range,affinity_parameter,affinity_high,affinity_median,affinity_low,original_affinity_units,original_affinity_low_nm,original_affinity_median_nm,original_affinity_high_nm,original_affinity_relation,assay_description,receptor_site,ligand_context,pubmed_id CNGA1,394,P29973,Human,dequalinium,2313,,2993,Nc1cc(C)[n+](c2c1cccc2)CCCCCCCCCC[n+]1c(C)cc(c2c1cccc2)N,"InChI=1S/C30H38N4/c1-23-21-27(31)25-15-9-11-17-29(25)33(23)19-13-7-5-3-4-6-8-14-20-34-24(2)22-28(32)26-16-10-12-18-30(26)34/h9-12,15-18,21-22,31-32H,3-8,13-14,19-20H2,1-2H3/p+2",PCSWXVJAIHCTMO-UHFFFAOYSA-P,Channel blocker,Antagonist,,,,,pIC50,,6.7,,,,,,=,,,,12508052, CNGA1,394,P29973,Human,cyclic GMP,2347,,135398570,O[C@@H]1[C@@H]2OP(=O)(O)OC[C@H]2O[C@H]1n1cnc2c1nc(N)[nH]c2=O,"InChI=1S/C10H12N5O7P/c11-10-13-7-4(8(17)14-10)12-2-15(7)9-5(16)6-3(21-9)1-20-23(18,19)22-6/h2-3,5-6,9,16H,1H2,(H,18,19)(H3,11,13,14,17)/t3-,5-,6-,9-/m1/s1",ZOOGRGPOEVQQDX-UUOKFMHZSA-N,Activator,Agonist,,yes,,,pKi,4.22,,4.07,Ki,85000.0,,60000.0,=,,,,7526403|1379636|7479749|9512030|7530019|9874685|12467592, CNGA1,394,Q62927,Rat,H-8,2348,,3540,CNCCNS(=O)(=O)c1cccc2c1ccnc2,"InChI=1S/C12H15N3O2S/c1-13-7-8-15-18(16,17)12-4-2-3-10-9-14-6-5-11(10)12/h2-6,9,13,15H,7-8H2,1H3",PJWUXKNZVMEPPH-UHFFFAOYSA-N,Channel blocker,Antagonist,,,,,pIC50,,3.5,,,,,,,,,,9324234, CNGA1,394,P29973,Human,L-(cis)-diltiazem,2349,,198107,COc1ccc(cc1)[C@H]1Sc2ccccc2N(C(=O)[C@H]1OC(=O)C)CCN(C)C,"InChI=1S/C22H26N2O4S/c1-15(25)28-20-21(16-9-11-17(27-4)12-10-16)29-19-8-6-5-7-18(19)24(22(20)26)14-13-23(2)3/h5-12,20-21H,13-14H2,1-4H3/t20-,21+/m0/s1",HSUGRBWQSSZJOP-LEWJYISDSA-N,Channel blocker,Antagonist,high affinity binding requires presence of CNGB subunits,,,,pKi,,4.0,,Ki,,100000.0,,=,,,,7682292,